Patent Assignment
Reel/Frame 021339/0977
Assignment of Assignor's Interest
Recorded: 2008-08-07
Pages: 9
Assignor
NPS ALLELIX CORP.
Executed: 2008-07-28
Assignee
NPS PHARMACEUTICALS, INC.
550 HILLS DRIVE, THIRD FLOOR, BEDMINSTER, NEW JERSEY, 07921
Covered Properties
(97)
Method for Enzymatic Production of Glp-2(1-33) and Glp-2(1-34) Peptides
Production of Glucagon-Like Peptide 2
Treatment of Short Bowel Syndrome Patients with Colon-In-Continuity
Biomarker of Improved Intestinal Function
Application:
11/606,896 →
Publication:
US US20070184554A1
Assay System for Glp-2 Receptor Ligands
Diaryl-Enynes
Patent:
6,426,364 →
Application:
09/704,225 →
Diaryl-Enynes
Diaryl-Enynes
Glyt-1 Inhibitors
Cloned Glucagon-Like Peptide 2 Receptors
Patent:
6,077,949 →
Application:
08/845,546 →
Intestinotrophic Glucagon-Like Peptide-2 Analogs
Patent:
6,184,201 →
Application:
08/835,538 →
Antagonists of Intestinotrophic Glp-2 Peptides
Patent:
5,994,500 →
Application:
08/683,890 →
Antagonists of Intestinotrophic Glp-2 Peptides
Patent:
6,489,295 →
Application:
09/233,934 →
Ampa-Binding Human GLUR3 Receptors
Patent:
6,413,739 →
Application:
08/896,063 →
Glp-2 Formulations
Excretion of Heterologous Proteins from E. Coli
Patent:
5,223,407 →
Application:
07/395,797 →
Excretion of Heterologous Proteins from E. Coli
Patent:
5,646,015 →
Application:
08/439,132 →
Human NR2A Binding Assay
Patent:
6,489,124 →
Application:
08/217,704 →
Ionotropic Human Glutamate Recepyor Subunit NR3
Patent:
6,391,566 →
Application:
08/264,578 →
Ampa-Binding Human GLUR2 Receptors
Patent:
6,399,313 →
Application:
08/439,946 →
Ampa-Binding Human GLUR2 Receptors
Patent:
6,441,155 →
Application:
08/242,344 →
Ampa-Binding Human GLUR4 Receptors
Patent:
6,372,488 →
Application:
08/473,204 →
Polynucleotides Encoding Ampa-Binding Human GLUR4 Receptors
Patent:
5,643,785 →
Application:
08/259,164 →
Ampa-Binding Human GLUR4 Receptors
Ampa-Binding Human GLUR4 Receptor Methods
Patent:
6,358,693 →
Application:
08/403,663 →
Ampa-Binding Human GLUR1 Receptors
Patent:
6,406,868 →
Application:
08/216,326 →
Ampa-Binding Human GLUR3 Receptors
Ampa-Binding Human GLUR3 Receptors
Patent:
6,403,323 →
Application:
08/257,029 →
Ampa-Binding Human GLUR2 Receptors
Patent:
6,040,175 →
Application:
08/483,327 →
Kainate-Binding, Human Cns Receptors of the EAA4 Family
Patent:
6,376,200 →
Application:
08/249,241 →
Glutamate Receptor (or Eaa Receptor) Polynucleotides and Their Uses
Patent:
6,136,544 →
Application:
08/666,221 →
Kainate-Binding, Human Cns Receptors of the EAA3 Family
Patent:
6,500,624 →
Application:
08/189,738 →
Kainate-Binding Human Cns Glutamate Receptors EAA3C and EAA3D, Dna Enc Oding Them, and Expression of the Dna in Transformed Cells
Patent:
5,547,855 →
Application:
08/405,392 →
Human Cns Receptors of the Nmda-R1 Family
Patent:
6,500,634 →
Application:
08/164,487 →
Kainate-Binding, Human Cns Receptors of the EAA5 Family
Patent:
6,333,161 →
Application:
08/178,019 →
Dna Encoding Kainate-Binding, Human Cns Receptors of the EAA5 Family
Patent:
6,322,999 →
Application:
08/377,503 →
Kainate-Binding, Human Cns Receptors of the EAA2 Family
Patent:
5,981,704 →
Application:
08/822,238 →
Kainate-Binding Human Cns Receptors of the EAA2 Family
Patent:
5,614,406 →
Application:
08/203,676 →
Kainate-Binding Human Cns Receptors of the EAA1 Family
Patent:
5,576,205 →
Application:
08/185,232 →
An Isolated Human Edg-4 Receptor
Compounds Having 5-HT6 Receptor Antagonist Activity
Patent:
6,897,215 →
Application:
10/111,404 →
Azaindoles Having Serotonin Receptor Affinity
Patent:
6,686,374 →
Application:
09/636,592 →
Mammalian Edg-7 Receptor Homologs
3-Bicycloindole Compounds
Patent:
6,562,809 →
Application:
09/156,496 →
An Isolated Edg-4 Receptor and Polynucletide Encoding Said Receptor
Patent:
6,482,609 →
Application:
09/582,200 →
N-Alkylamino-Indoles for the Treatment of Migraine
Patent:
6,380,242 →
Application:
09/469,327 →
5-Bicycloindole Compounds
Patent:
6,329,390 →
Application:
09/116,946 →
Methods Useful in the Treatment of Bone Resorption Diseases
Patent:
6,284,730 →
Application:
09/125,247 →
Bicyclic Piperidine and Piperazine Compounds Having 5-HT6 Receptor Affinity
Patent:
6,251,893 →
Application:
09/156,495 →
Azaindoles Having Serotonin Receptor Affinity
Patent:
6,191,141 →
Application:
09/373,212 →
Production of Human Parathyroid Hormone from Microorganisms
Patent:
6,146,852 →
Application:
08/461,436 →
Piperidine-Indole Compounds Having 5-HT6 Affinity
Patent:
6,133,287 →
Application:
09/046,669 →
Pyrrolidine-Indole Compounds Having 5-HT6 Affinity
Patent:
6,100,291 →
Application:
09/039,269 →
Essentially Pure Human Parathyroid Hormone
Patent:
5,208,041 →
Application:
07/707,114 →
Mammalian Edg-5 Receptor Homologs
Patent:
6,057,126 →
Application:
08/997,803 →
Isolated Polynucleotide for Novel G-Protein Coupled Receptor
Patent:
6,020,158 →
Application:
08/861,747 →
5-Alkyl Indole Compounds
Patent:
5,998,462 →
Application:
08/767,323 →
5-Cyclo Indole Compounds
Patent:
5,998,438 →
Application:
08/976,103 →
5-Alkenyl and 5-Alkynyl Indole Compounds
Patent:
5,856,510 →
Application:
08/767,322 →
Expression of Human D4 Dopamine Receptors in Stable Cell Lines
Patent:
5,846,823 →
Application:
08/623,471 →
Alkyl-Substituted Compounds Having Dopamine Receptor Affinity
Patent:
5,834,459 →
Application:
08/754,014 →
Selective Template Deletion Method
Patent:
5,830,712 →
Application:
08/597,249 →
Glucagon-Like Peptide-2 Analogs
Patent:
5,789,379 →
Application:
08/669,791 →
Bicyclic Nonane and Decane Compounds Having Dopamine Receptor Affinity
Patent:
5,703,072 →
Application:
08/625,358 →
N-Methyl Piperazine Compounds Having Dopamine Receptor Affinity
Patent:
5,700,445 →
Application:
08/354,905 →
Treatment of Cytomegalovirus Infection
Patent:
5,633,230 →
Application:
08/332,518 →
Anti-Viral Guanidino-Substituted Compounds
Patent:
5,627,194 →
Application:
08/322,492 →
5-HT2 Receptor Ligands
Patent:
5,602,124 →
Application:
08/354,765 →
Alkyl-Substituted Compounds Having Dopamine Receptor Affinity
Patent:
5,602,121 →
Application:
08/354,793 →
Benzyl-Substituted Compounds Having Dopamine Receptor Affinity
Patent:
5,602,120 →
Application:
08/354,766 →
Bone-Stimulating, Non-Vasoactive Parathyroid Hormone Variants
Patent:
5,599,792 →
Application:
08/332,453 →
Kainate-Binding, Human Cns Receptors of the EAA4 Family
Patent:
5,574,144 →
Application:
07/903,456 →
Muscarinic Receptor Ligands
Patent:
5,561,127 →
Application:
08/358,471 →
5-Ht-1D Receptor Ligands
Patent:
5,504,101 →
Application:
08/238,823 →
Parathyroid Hormone Formulation
Patent:
5,496,801 →
Application:
08/172,206 →
Antiviral Polynucleotide Conjugates
Patent:
5,495,006 →
Application:
08/024,254 →
Dna Encoding Variants of Human Corticosteroid Binding Globulin
Patent:
5,432,080 →
Application:
07/994,423 →
Method for Isolating a Soluble Osteogenic Factor from Bone
Patent:
5,403,825 →
Application:
07/937,744 →
Stability-Enhanced Variants of Parathyroid Hormone
Patent:
5,382,658 →
Application:
07/863,014 →
Pharmaceutical Compositions for Use in Treating Inflammation
Patent:
5,344,819 →
Application:
07/829,954 →
Ultrapure Human Interleukin-6
Patent:
5,338,834 →
Application:
08/009,973 →
Method of Purifying Human Epidermal Growth Factor
Patent:
5,290,920 →
Application:
07/869,176 →
Egf Variants and Pharmaceutical Use Thereof
Patent:
5,218,093 →
Application:
07/317,467 →
Recombinant Dna System for Aspergillus
Patent:
5,171,672 →
Application:
07/401,319 →
Isolated Osteogenic Factor
Patent:
5,169,837 →
Application:
07/676,179 →
Vinblastine Synthesis
Patent:
5,034,320 →
Application:
07/032,459 →
Pharmaceutical Compositions and Use Thereof in Treating Inflammation
Patent:
4,997,814 →
Application:
07/204,356 →
Treating Inflammation with Hepatocyte Stimulating Factor Interferon Beta 2
Patent:
4,973,478 →
Application:
07/075,809 →
Shuttle Vectors from Rhodococcus Equi
Patent:
4,920,054 →
Application:
06/889,204 →
Enzymatic Preparation of 3',4'-Anhydrovinblastine
Patent:
4,918,011 →
Application:
06/893,018 →
Process for Extracting Methylxanthines from Aqueous Solutions Containing Same
Patent:
4,904,773 →
Application:
07/023,619 →
Aspergillus Niger Transformation System
Patent:
4,885,249 →
Application:
06/678,578 →
Fermentation Vessels
Patent:
4,847,203 →
Application:
07/090,906 →
Extraction of Alkaloids of Catharanthus Roseus Tissue
Patent:
4,831,133 →
Application:
07/045,621 →
Production of Alkaloid Dimers Using Ferric Ion
Patent:
4,778,885 →
Application:
06/908,991 →
Device for Performing Immunochemical Assays
Patent:
4,729,875 →
Application:
06/880,948 →
Device for Performing Enzyme Immunoassays
Patent:
4,690,801 →
Application:
06/870,320 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 15, 2010
From: SANGUINETTI, ELIZABETH L; MARRIOTT, THOMAS B; LOPANSRI, JENNIFER; BLOSCH, CONSUELO M
To: NPS ALLELIX CORP
Reel/Frame 024081/0573 →
Change of Name
Dec 23, 2016
From: NPS PHARMACEUTICALS, INC.
To: SHIRE-NPS PHARMACEUTICALS, INC.
Reel/Frame 041187/0545 →
Change of Name
Jan 23, 2017
From: NPS PHARMACEUTICALS, INC.
To: SHIRE-NPS PHARMACEUTICALS, INC.
Reel/Frame 041069/0687 →
Change of Name
Jan 23, 2017
From: NPS PHARMACEUTICALS, INC.
To: SHIRE-NPS PHARMACEUTICALS, INC.
Reel/Frame 041069/0898 →
Change of Address
Jul 19, 2018
From: SHIRE-NPS PHARMACEUTICALS, INC.
To: SHIRE-NPS PHARMACEUTICALS, INC.
Reel/Frame 046598/0592 →
Change of Address
Jul 19, 2018
From: SHIRE-NPS PHARMACEUTICALS, INC.
To: SHIRE-NPS PHARMACEUTICALS, INC.
Reel/Frame 046612/0742 →